glp 1 agonist drug names GLP-1 Agonists Examples: Which One Wins? List of approved and pending

Riediger, T., Rauch, M

The Medicines and Healthcare products Regulatory Agency (MHRA) and manufacturers' Summaries of Product Characteristics (SmPCs) consistently advise against using GLP-1 receptor agonists whilst breastfeeding due to insufficient data on excretion into human breast milk and potential effects on nursing infants

Yes, well take the burden off your shoulders

M2 macrophage-membrane camouflaged BBR NPs@Mannose enhance targeting and immune evasion while prolonging circulation half-life in an atherosclerosis mouse model [177]

Buteau J, Foisy S, Rhodes CJ, et al

Compared with basal insulin, both tirzepatide 5 mg and tirzepatide 15 mg were associated with increased odds of discontinuation of study medication due to adverse events (ESM Table 3)